Join Nutricia Metabolics Webinar 7th December

As part of our ongoing commitment to provide high quality scientific education to support healthcare professionals, Nutricia Metabolics releases the second in a series of webinars focusing on rare metabolic disorders beyond PKU on Wednesday 7th December 18:00-19:30 CET.

boy-paddleboarding-in-river
organic-acidaemias-webinar-poster

Organic acidaemias

International expert speakers will share the latest insights into the management of organic acidaemias. Join them and participate in a live question and answers sessions. A parent will also share their experience of the journey with a child diagnosed with GA1, an organic acidaemia, from diagnosis to teenage years.

The Nutricia Metabolics Webinar is intended for healthcare professionals only.

Register here
PROGRAM
18:00-18:35 CET

Introduction to the Organic Acidaemias and their Management

Dr Andrew Morris, Consultant Paediatrician and Lead Clinician in Inherited Metabolic Medicine, Manchester Royal Infirmary, UK
18:35-19:00 CET

Overview of the Principles of Dietary Management with Case Study Examples

Marjorie Dixon, Clinical Lead Dietitian for Metabolic Medicine, Great Ormond Street Hospital, London, UK
19:00-19:10

Testimonial from a parent of a child with GA1 on their journey from diagnosis to teenage hood

19:10-19:30

Live interactive Q&A with our speakers

Andrew Morris

Andrew Morris, Consultant Clinical Paediatrician in Inherited Metabolic Medicine Manchester UK

Marjorie Dixon

Marjorie Dixon, Clinical Lead Dietitian for Metabolic Medicine London UK


Contact

Please email: clare.szwec@danone.com for any questions.

Metabolism happy children sofa

Inherited Metabolic Disorders

Inherited metabolic disorders (IMDs), also known as Inborn errors of metabolism (IEM) are a group of rare disorders caused by genetic defects.

nutricia-PKU-BH4-graphical-abstract

Learn more about latest research

News article about recent systematic review and meta-analysis exploring why protein substitutes are still very relevant to patients with PKU on BH4 treatment.